PMI’s Science-Led shift: Dr. Moira Gilchrist argues for Tobacco Harm Reduction at Technovation 2024

economictimes.indiatimes.com:

At Technovation, science takes centre stage, playing a crucial role in the evolving landscape of tobacco alternatives. Philip Morris International (PMI) recently hosted its ninth Technovation event ‘30 years of innovation, 10 years of progress at the Cube, its R&D centre in Neuchâtel, Switzerland. In this context, PMI’s Chief Communications Officer, Dr. Moira Gilchrist, shares her perspective on the critical role of science & technology in driving PMI's commitment to a smoke-free future.

1. What made you choose PMI & tobacco as a sector, given your rich experience in pharmacy & medicine

I was a consultant in the pharmaceutical industry, helping companies evolve their operations. One day, our consulting firm was approached by PMI. They wanted our expertise to build a science strategy akin to that of a pharmaceutical company rather than a tobacco one. Initially, we were puzzled.

We traveled to meet PMI’s R&D head in 2005. I was captivated by their idea to create products for adult smokers that are less risky than smoking. The organization recognized that science would need to be rigorous and capable of withstanding regulatory scrutiny. Switching from pharma to tobacco was a tough decision, but as a scientist and ex-smoker, the opportunity to play a role in building a smoke-free future was too important to ignore.

2. PMI’s transformation journey is looked at with much skepticism — is this science & innovation or just a diversified business strategy?

I am a firm believer that science should be front and center in policymaking, business, and everyday life, as it can help make significant strides in our collective efforts to address the world's most pressing problems.

Rese